{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:36:04Z","timestamp":1793039764918,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173787"],"award-info":[{"award-number":["82173787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.antiviral.2026.106516","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:22:48Z","timestamp":1787095368000},"page":"106516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor"],"prefix":"10.1016","volume":"254","author":[{"given":"Jintao","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2233-3335","authenticated-orcid":false,"given":"Lingyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6422-2401","authenticated-orcid":false,"given":"De","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.antiviral.2026.106516_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080805","article-title":"Angiotensin-converting enzyme 2 (ACE2) in the context of respiratory diseases and its importance in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"14","author":"Ambrocio-Ortiz","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"7839","key":"10.1016\/j.antiviral.2026.106516_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106516_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"issue":"6515","key":"10.1016\/j.antiviral.2026.106516_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"issue":"7898","key":"10.1016\/j.antiviral.2026.106516_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.antiviral.2026.106516_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104935","article-title":"Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern","volume":"25","author":"Chaouat","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib7","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1038\/s41467-025-61741-x","article-title":"Structural insights into pre-pore intermediates of alpha-hemolysin in the lipidic environment","volume":"16","author":"Chatterjee","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.antiviral.2026.106516_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2025.01.042","article-title":"Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor","volume":"188","author":"Chen","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","article-title":"ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"20","key":"10.1016\/j.antiviral.2026.106516_bib10","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1016\/j.cell.2024.07.052","article-title":"Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals","volume":"187","author":"Cohen","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.antiviral.2026.106516_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2026.106516_bib12","article-title":"Protein complex prediction with AlphaFold-Multimer","volume":"2021","author":"Evans","year":"2022","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.antiviral.2026.106516_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/CVI.00091-16","article-title":"Auto-assembling detoxified Staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin","volume":"23","author":"Fiaschi","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib14","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1038\/s41467-024-51046-w","article-title":"Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways","volume":"15","author":"Gagne","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/22221751.2021.1956373","article-title":"Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor","volume":"10","author":"Guo","year":"2021","journal-title":"Emerg. Microb. Infect."},{"issue":"7","key":"10.1016\/j.antiviral.2026.106516_bib16","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"9","key":"10.1016\/j.antiviral.2026.106516_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00002-21","article-title":"SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in their requirements for receptor expression and proteolytic activation","volume":"95","author":"Hornich","year":"2021","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41392-022-01037-4","article-title":"A robust reporting system for measurement of SARS-CoV-2 spike fusion efficiency","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MNH.0b013e32831b70ad","article-title":"Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease","volume":"18","author":"Ingelfinger","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib20","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/s41467-023-38457-x","article-title":"saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern","volume":"14","author":"Komori","year":"2023","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.antiviral.2026.106516_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7807","key":"10.1016\/j.antiviral.2026.106516_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.antiviral.2026.106516_bib23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-022-00859-0","article-title":"Ferritin - a multifaceted protein scaffold for biotherapeutics","volume":"54","author":"Lee","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106516_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"2","key":"10.1016\/j.antiviral.2026.106516_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020997","article-title":"The abundant distribution and duplication of SARS-CoV-2 in the cerebrum and lungs promote a high mortality rate in transgenic hACE2-C57 mice","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6965","key":"10.1016\/j.antiviral.2026.106516_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.antiviral.2026.106516_bib27","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41418-021-00795-y","article-title":"Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes","volume":"28","author":"Lin","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib28","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/s41467-023-40933-3","article-title":"An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106516_bib29","doi-asserted-by":"crossref","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.antiviral.2026.106516_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.antiviral.2026.106516_bib31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cell.2024.12.031","article-title":"Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses","volume":"188","author":"Ma","year":"2025","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.antiviral.2026.106516_bib32","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3201\/eid2812.220801","article-title":"Isolation of bat sarbecoviruses, Japan","volume":"28","author":"Murakami","year":"2022","journal-title":"Emerg. Infect. Dis."},{"issue":"10","key":"10.1016\/j.antiviral.2026.106516_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41573-022-00501-8","article-title":"Avidity in antibody effector functions and biotherapeutic drug design","volume":"21","author":"Oostindie","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7896","key":"10.1016\/j.antiviral.2026.106516_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"issue":"7903","key":"10.1016\/j.antiviral.2026.106516_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41586-022-04464-z","article-title":"ACE2 binding is an ancestral and evolvable trait of sarbecoviruses","volume":"603","author":"Starr","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.antiviral.2026.106516_bib36","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.ymthe.2023.09.002","article-title":"Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib37","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s42003-025-08704-6","article-title":"Single-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection","volume":"8","author":"Sun","year":"2025","journal-title":"Commun. Biol."},{"issue":"51","key":"10.1016\/j.antiviral.2026.106516_bib38","doi-asserted-by":"crossref","first-page":"21541","DOI":"10.1021\/jacs.1c08226","article-title":"Spherical neutralizing aptamer inhibits SARS-CoV-2 infection and suppresses mutational escape","volume":"143","author":"Sun","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"10.1016\/j.antiviral.2026.106516_bib39","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41467-021-21240-1","article-title":"Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia","volume":"12","author":"Wacharapluesadee","year":"2021","journal-title":"Nat. Commun."},{"issue":"8068","key":"10.1016\/j.antiviral.2026.106516_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41586-025-09007-w","article-title":"A MERS-CoV-like mink coronavirus uses ACE2 as an entry receptor","volume":"642","author":"Wang","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.antiviral.2026.106516_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"7866","key":"10.1016\/j.antiviral.2026.106516_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","article-title":"Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xu","year":"2021","journal-title":"Nature"},{"issue":"7992","key":"10.1016\/j.antiviral.2026.106516_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","article-title":"Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization","volume":"624","author":"Ye","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.antiviral.2026.106516_bib45","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradnik","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"6","key":"10.1016\/j.antiviral.2026.106516_bib46","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41564-023-01389-9","article-title":"Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies","volume":"8","author":"Zhang","year":"2023","journal-title":"Nat. Microbiol."},{"issue":"3","key":"10.1016\/j.antiviral.2026.106516_bib47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","article-title":"SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.antiviral.2026.106516_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2174755","article-title":"Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2","volume":"19","author":"Zhang","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"issue":"17","key":"10.1016\/j.antiviral.2026.106516_bib49","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1016\/j.cell.2021.06.008","article-title":"Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"},{"issue":"7798","key":"10.1016\/j.antiviral.2026.106516_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:09Z","timestamp":1793036589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226001750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0166354226001750"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106516","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106516"}}